• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Dr. Reddy's to buy Roche's Mexico Bulk Drugs Unit

      Posted AtReuters

      Drug maker Dr. Reddy's Laboratories Ltd. said on Tuesday it had signed an agreement to acquire Roche's active pharmaceutical ingredients business in Mexico for $59 million.

      It said the all-cash deal, to be completed by the end of December, included 340 employees at the site in Cuernavaca and all its business supply contracts. The unit makes and sells bulk drugs to Roche and other innovator pharmaceutical companies.

      Dr. Reddy's said in a statement it expected the unit to add to earnings and saw the full impact from the next financial year. Its shares rose 1 percent to 897 rupees in a firm Mumbai market.

      With the acquisition, Dr. Reddy's said it hoped to become a leading player in custom pharmaceutical services, targeting big pharma companies, and forecast its revenue from the business could grow to $100 million in 18 months from $10 million now.

      Roche's Mexican portfolio has 18 products. Dr. Reddy's said the buyout also gave it unique steroid manufacturing capability.

      Hyderabad-based Dr. Reddy's has posted poor financial results in the past few years due to a lack of blockbuster generics for sale in the U.S. market and high research and development costs. It is now trying to retune its operations to get back on track.

      It sold its 49 percent stake in Pathnet India, a joint venture with Australia's Gribbles Pathology, in July this year for an undisclosed amount. It has also structured deals with venture capitalists in a bid to reduce its research costs.

      A company official said Dr. Reddy's would be left with about $115 million cash in hand after the Mexico acquisition.

      November 08, 2005


      Share this Article!

    Back to top^